HOME >> BIOLOGY >> NEWS
Stanford receives funding for unique cancer and stem cell biology institute

STANFORD, Calif. -- Stanford University has received a $12 million commitment from an anonymous donor to establish a new Institute for Cancer/Stem Cell Biology and Medicine, a multi-disciplinary initiative that is believed to be the first of its kind in the country, it was announced today. The institute will bring together basic and clinical scientists in a unified effort that will harness the power of stem cell biology and cancer biology to develop novel treatments for cancer as well as other devastating diseases such as diabetes, Parkinson's disease and cardiovascular disease. The institute will be directed by renowned stem cell researcher Irving Weissman, MD, the Karel H. and Avice N. Beekhuis Professor in Cancer Biology.

"This is a major undertaking that will capitalize on Stanford's expertise in stem cell and cancer research. It exemplifies our goal of translating the fruits of laboratory research into therapies that will directly benefit patients," said Philip A. Pizzo, MD, dean of the School of Medicine and a distinguished cancer researcher.

Weissman said research in his lab and elsewhere suggests that in some cancers, such as leukemia, the cancer cells grow and proliferate in much the same way as stem cells. Scientists at the new institute will explore these similarities with the goal of developing powerful new stem cell-based therapies to treat cancer, he said.

"What we're doing is examining these two fields that we thought were separate and looking at the overlap that exists between them," Weissman said.

He said institute scientists also will work to develop a new series of embryonic stem cell lines that will serve as models for a wide range of genetically related diseases including cancer, diabetes, cardiovascular disease, autoimmune disease, allergies and neurodegenerative disorders such as Parkinson's and Lou Gehrig's disease.

"We want to translate the advances i
'"/>

Contact: Neale Mulligan
nealem@stanford.edu
1-650-724-2454
Stanford University Medical Center
10-Dec-2002


Page: 1 2 3

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Stanford researchers findings may shed light on common, deadly birth defect
3. Leukemia stem cells identified by Stanford researchers
4. New view of leukemia cells identifies best treatment options, Stanford researchers say
5. Confidentiality of genetic databases questioned by Stanford researchers
6. Stanford researchers go from heaven to Earth in lifeguard test
7. Transplant rejection averted by simple light exposure in Stanford animal study
8. Fat cells heal skull defects in mice, Stanford research shows
9. Gene-based screen sorts cancer cases, say Stanford researchers
10. Elusive but ubiquitous microbe fingered as gum disease culprit in Stanford study
11. Sticklebacks reveal secrets to evolutionary change in Stanford study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 15, 2019 , ... ... exclusively for Life Sciences and Healthcare companies, announces the availability of new specialty ... and strategic direction to start-up and emerging bio-pharma companies interested in achieving specific ...
(Date:7/9/2019)... ... 2019 , ... Murrieta Genomics, a launch pad for genomic ... and CEO of Tx Genetic, Helen Harrison, has spent several years researching and ... tissue disorders. , “We are pleased and excited to join the growing health ...
(Date:6/25/2019)... ... June 25, 2019 , ... ActX ... raw data, easily available from 23andMe, customers can get access to professionally reviewed ... available for both 23andMe Ancestry and Health + Ancestry customers., With the ActX ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 10, 2019 , ... ... and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check your local ... Group) and will educate viewers about how its technology facilitates laboratories to improve ...
(Date:6/6/2019)... , ... June 05, 2019 , ... WCCT Global, ... medical device industries, announced today that they will be receiving 3 awards at the ... CA. WCCT received 2 awards in the categories of overall Quality and Compatibility (Access ...
(Date:5/31/2019)... ... May 30, 2019 , ... A study released today in ... for the sustained release of human placental stem cell (HPSC)-derived conditioned medium (CM) ... deliver CM into the injured kidney, where it helped restore function and regenerate ...
(Date:5/14/2019)... ... May 13, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is ... redesigned website aims to improve LDA’s ability to communicate directly with the marketplace; ...
Breaking Biology Technology:
Cached News: